HLA class II pepride binding specificity and autoimmunity

Advances in Immunology

Volumn 66, Issue , 1997, Pages 67-100

  Hammer, Juergen ^a   Sturniolo, Tiziana ^a   Sinigaglia, Francesco ^a  

^a ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN BINDING; ANTIGEN EXPRESSION; AUTOIMMUNITY; ETIOLOGY; HUMAN; IMMUNOPATHOGENESIS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0030930763     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (114)

1. Ahmed, A. R., Yunis, E. J., Khatri, K., Wagner, R., Notani, G., Awdeh, Z., and Alper, C. A. (1990). Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 87, 7658-7662.
2. Ahmed, A. R., Wagner, R., Khatri, K., Notani, G., Awdeh, Z., Alper, C. A., and Yunis, E. J. (1991). Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 88, 5056-5060.
3. Amagai, M., Klaus-Kovtun, V., and Stanley, J. R. (1991). Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67, 869-877.
4. Awata, T., Kuzuya, T., Matsuda, A., Iwamoto, Y., Kanazawa, Y., Okuyama, M., and Juji, T. (1990). High frequency of aspartic acid at position 57 of HLA-DQ beta-chain in Japanese IDDM patients and nondiabetic subjects. Diabetes 39, 266-269.
5. Beale, R., and Jackson, T. (1990). "Neural Computing: An Introduction", Hilger, Bristol, UK.
6. Boehncke, W. H., Takeshita, T., Pendleton, C. D., Houghten, R. A., Sadegh, N., Racioppi, S., Berzofsky, J. A., and Germain, R. N. (1993). The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J. Immunol. 150, 331-341.
7. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., and Wiley, D. C. (1993). The three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364, 33-39.
8. Brusic, V., Rudy, G., and Harrison, L. C. (1994). "Complex Systems: Mechanisms of Adaptation. " IOS Press, Amsterdam.
9. Brusic, V., Rudy, G., Honeyman, M., Hammer, J., and Harrison, L. C. (1997). Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Submitted for publication.
10. Campbell, R. D., and Trowsdale, J. (1994). Map of the human MHC. Immunol. Today 14, 349-352.
11. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A. A., Lane, W. S., and Strominger, J. L, (1993). Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178, 27-47.
12. Chicz, R. M., Lane, W. S., Robinson, R. A., Tmcco, M., Strominger, J. L., and Gorga, J. C. (1994). Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int. Immunol. 6, 1639-1649.
13. Cresswell, P. (1994). Assembly, transport and function of MHC class II molecules. Annu. Rev. Immunol. 12, 259-293.
14. Cwirla, S. E., Peters, E. A., Barret, R. W., and Dower, W. J. (1990). Peptides on phage: A vast library of peptides for identifying ligands. Biochemistry 87, 6378-6382.
15. Davenport, M. P., Ho Shon, I. A., and Hill, A. V. (1995). An empirical method for the prediction of T cell epitopes. Immunogenetics 42, 392-397.
16. Davies, J. L., Kawaguchi, Y., Bennett, S. T., Copeman, J. B., Cordell, H. J., Pritchard, L. E., Reed, P. W., Gough, S. C. L., Jenkins, S. C., Palmer, S. M., Balfour, K. M., Rowe, B. R., Farrall, M., Barnett, A. H., Bain, S. C, and Todd, J. A. (1994). A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371, 130-136.
17. DeLisi, C, and Berzofsky, J. A. (1985). T-cell antigenic sites tend to be amphipathic structures. Proc. Natl. Acad. Sci. USA 82, 7048-7052.
18. De Magistris, T. M., Alexander, J., Coggeshall, M., Altman, A., Gaeta, F. C. A., Grey, H. M., and Sette, A. (1992). Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68, 625-634.
19. Devlin, J. J., Paniganiban, L. C, and Devlin, P. E. (1990). Random peptide libraries: A source of specific protein binding molecules. Science 249, 404-406.
20. Enddoh, M., Tabira, T., Kunishita, T., Sakai, K., Yamamura, T., and Taketomi, T. (1986). A proteolipid apoprotein is an encephalitogen of acute and relapsing autoimmune encephalomyelitis in mice. J. Immunol. 137, 3832-3835.
21. Falk, K., and Rotzschke, O. (1993). Consensus motifs and peptide ligands of MHC class I molecules. Semin. Immunol. 5, 81-94.
22. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, H.-G. (1991). Allele specific motifs revealed by sequencing of self peptides eluted from MHC molecules. Nature 351, 290-296.
23. Falk, K., Roetzschke, O., Stevanovic, S., Jung, G., and Rammensee, H.-G. (1994). Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39, 230-242.
24. Forrest, S. (1993). Genetic algorithms: Principles of natural selection applied to computation. Science 261, 872-878.
25. Franco, A., Southwood, S., Arrhenius, T., Kucroo, V. K., Grey, H. M., Sette, A., and Ishioka, G. Y. (1994). T cell receptor antagonist peptides are effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 24, 940-946.
26. Friede, T., Gnan, V., Jung, G., Keilholz, W., Stevanovic, S., and Rammensee, H. (1996). Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides. Biochim. Biophys. Acta 1316, 85-101.
27. Fritz, R. B., Chou, C. H. J., and McFarlin, D. E. (1983). Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J. Immunol. 130, 1024-1026.
28. Fugger, L., Rothbard, J., and Sonderstrup-McDevitt, G. (1996). Specificity of an HLA-DRB1°0401 restricted T cell response to type II collagen. Eur. J. Immunol. 26, 928-933.
29. Gaston, J. S. H., Life, P. F., Jenner, P. J., Colston, M. J., and Bacon, P. A. (1990). Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J. Exp. Med. 171, 831-841.
30. Gaur, A., Wiers, B., Liu, A., Rothbard, J., and Fathman, C. G. (1992). Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258, 1491-1494.
31. Gautam, A. M., Pearson, C. I., Sinha, A. A., Smilek, D. E., Steinman, L., and McDevitt, H. O. (1992). Inhibition of experimental autoimmune encephalomyelitis by a nonimmuno-genic non-self peptide that binds to I-A". J. Immunol. 148, 3049-3054.
32. Geluk, A., Meijgaarden, K. E., Janson, A. A. M., Drijfhout, J. W., Meloen, R. H., Vries, R. R. P., and Ottenhof, T. H. M. (1992). Functional analysis of DR17 (DR3) -restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J. Immunol. 149, 2864-2871.
33. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D. C. (1995). The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378, 457-462.
34. Gregersen, P. K., Shen, M, Song, Q. L., Merryman, P., Degar, S., Seki, T., Maccari, J., Goldberg, D., Murphy, H., Schwenzer, J., Wang, C. Y., Winchester, R. J., Nepom, G. T., and Silver, J. (1986). Molecular diversity of HLA-DR4 haplotaypes. Proc. Natl. Acad. Sci. USA 83, 2642-2646.
35. Hammer, J., Takacs, B., and Sinigaglia, F. (1992). Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med. 176, 1007-1013.
36. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., and Sinigaglia, F. (1993). Promiscuous and allele-specific anchors in HLA-DR binding peptides. Cell 74, 197-203.
37. Hammer, J., Belunis, C., Bolin, D., Papadopoulos, J., Walsky, R., Higelin, J., Danho, W., Sinigaglia, F., and Nag, Z. A. (1994a). High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. Natl. Acad. Sci. USA 91, 4456-4460.
38. Hammer, J., Bono, E., Gallazzi, F., Belunis, C., Nagy, Z., and Sinigaglia, F. (1994b). Precise prediction of major histocompatibility complex class II peptide interaction based on peptide side chain scanning. J. Exp. Med. 180, 2353-2358.
39. Hammer, J., Gallazzi, F., Bono, E., Karr, R. W., Guenot, J., Valsasnini, P., Nagy, Z. A., and Sinigaglia, F. (1995). Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association. J. Exp. Med. 181, 1847-1855.
40. Hanson, G. J., Vuletich, J. L., Bedell, L. J., Bono, C. P., Howard, S. C., Woulfe, S. L., and Zacheis, M. L. (1996). Design of MHC class II (DR4) ligands using conformationally restricted iminoacids at p. 3 and p5. Bioorg. Med. Chem. Lett. 6, 1931-1936.
41. Holmdal, R., Andersson, M., Goldschmidt, K., Gustafsson, K., Jansson, L., and Mo, J. A. (1990). Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol. Rev. 118, 193-232.
42. Horn, G., Bugawan, T., Long, C, and Erlich, H. (1988). Allelic sequence variation of the HLA DQ loci: Relationship to serology and to IDDM susceptibility. Proc. Natl. Acad. Sci. USA 85, 6012-6016.
43. Hunt, D. F., Michel, H., Dickinson, T. A., Shabonawitz, J., Cox, A. L., Sakaguchi, K., Apella, E., Grey, H. M., and Sette, A. (1992). Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256, 1817-1820.
44. Hurtenbach, U., Lier, E., Adorini, L., and Nagy, Z. A. (1993). Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide. J. Exp. Med. 177, 1499-1504.
45. Ito, K., Bian, H.-J., Molina, M., Han, J., Magram, J., Saar, E., Belunis, C., Bolin, D. R., Arceo, R., Campbell, R., Falcioni, F., Vidovic, D., Hammer, J., and Nagy, Z A. (1996). HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183, 2635-2644.
46. Jameson, S. C., Carbone, F. R., and Bevan, M. J. (1993). Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177, 1541-1550.
47. Jardetzky, T. S., Gorga, J. C., Busch, R., Rothbard, J. B., Strominger, J. L., and Wiley, D. C. (1990). Peptide binding to HLA-DR1: A peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9, 1797-1804.
48. Johansen, B. H., Vartdal, F., Eriksen, J. A., Thorsby, E., and Sollid, L. M. (1995). Identification of a putative motif for binding of peptides to HLA-DQ2. Int. Immunol. 8, 177-182.
49. Kappler, J., Roehm, N., and Marrack, P. (1987). T cell tolerance by clonal elimination in the thymus. Cell 49, 273-280.
50. Kaufman, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S. P., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., and Lehmann, P. V. (1993). Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366, 69-72.
51. Krieger, J. I., Karr, R. W., Grey, H. M., Yu, W.-Y., O'Sullivan, D., Batovsky, L., Zheng, Z.-L., Colon, S. M., Gaeta, F. C. A., Sidney, J., Albertson, M., Del Guercio, F. C. A., Chesnut, R. W., and Sette, A. (1991). Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J. Immunol. 146, 2331-2340.
52. Kwok, W. W., Domeier, M. E., Johnson, M. L., Nepom, G. T., and Koelle, D. M. (1996a). HLA-DQB1 codon 57 is critical for peptide binding and recognition. J. Exp. Med. 183, 1253-1258.
53. Kwok, W. W., Domeier, M. E., Raymond, F. C., Byers, P., and Nepom, G. T. (1996b). Allele-specific motifs characterize HLA-DQ interaction with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156, 2171-2177.
54. Lamont, A. G., Powell, M. F., Colon, S. M., Miles, G., Grey, H. M., and Sette, A. (1990). The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo. J. Immunol. 144, 2493-2498.
55. Lund, T., O'Reilly, L., Hutchings, P., Kanagawa, O., Simpson, E., Gravely, R., Chandler, P., Dyson, J., Picard, J. K., Edwards, A., Kioussis, D., and Cooke, A. (1990). Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta chain or normal I-E alpha-chain. Nature 345, 727-729.
56. Madden, D. R., Gorga, J. C., Strominger, J. L., and Wiley, D. C. (1991). The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353, 321-325.
57. Malcherek, G., Falk, K., Roetzschke, O., Rammensee, H.-G., Stevanovic, S., Gnau, V., Jung, G., and Melms, A. (1993). Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int. Immunol. 5, 1229-1237.
58. Markovic-Plese, S., Fukaura, H., Zhang, J., Al-Sabbagh, A., Southwood, S., Sette, A., Kuch-roo, V. K., and Hafler, D. A. (1995). T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155, 982-992.
59. Marrosu, M. G., Muntoni, F., Murru, M. R., Spinicci, G., Pischedda, M. P., Goddi, F., Cassu, P., and Piratsu, M. (1988). Sardinian multiple sclerosis is associated with HLA-DR4: A serologic and molecular analysis. Neurology 348, 1749-1753.
60. Marsh, S. G. E., and Bodmer, J. G. (1995). HLA class II region nucleotide sequences, 1995. Tissue Antigens 45, 258-280.
61. °0401. J. Immunol. 154, 5927-5933.
62. Martin, R., Jaraquemada, D., Flerlage, M., Richert, J., Whitaker, J., Long, E. O., McFarlin, D. E., and McFarland, H. F. (1990). Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145, 540-548.
63. Matsumura, M., Fremont, D. H., Peterson, P. A., and Wilson, I. A. (1992). Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927-934.
64. Matsushita, S., Takahashi, K., Motoki, M., Komoriya, K., Ikagawa, S., and Nishimura, Y. (1994). Allele specificity of structural requirement for peptides bound to HLA-DRB1°0405 and -DRB1 °0406 complexes: Implication for the HLA-associated susceptibility to methim-azole-induced insulin autoimmune syndrome. J. Exp. Med. 180, 873-883.
65. Mikecz, K., Giant, T. T., and Poole, A. R. (1987). Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and nkylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum. 30, 306-318.
66. Morel, P. A., Dorman, J. S., Todd, J. A., McDevitt, H. O., and Trucco, M. (1988). Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes. A family study. Proc. Natl. Acad. Sci. USA 85, 8111-8115.
67. Nepom, G. T., and Erlich, H. A. (1991). MHC class II molecules and autoimmunity. Annu. Rev. Immunol. 9, 493-520.
68. Nepom, G. T., Byers, P., Seyfried, C., Healey, L. A., Wilskie, K. R., Stage, D., and Nepom, B. S. (1989). HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotides probes. Arthritis Rheum. 32, 15-21.
69. Nepom, B. S., Nepom, G. T., Coleman, M., and Kwok, W. (1996). Critical contribution of b chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. USA 93, 7202-7206.
70. O'Sullivan, D., Arrhenius, T., Sidney, J., Del Guercio, M.-F., Albertson, M., Wall, M., Oseroff, C., Southwood, S., Colón, S. M., Gaeta, F. C. A., and Sette, A. (1991). On the interaction of promiscuous antigenic peptides with different DR alleles. J. Immunol. 147, 2664-2669.
71. Ota, K., Matsui, M., Milford, E. L., Mackin, G. A., Weiner, H. L., and Hafler, D. A. (1990). T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346, 183-187.
72. Otha, N., Nishimura, Y. K., Tanimoto, T., et al. (1982). Association between HLA and Japanese patients with rheumatoid arthritis. Hum. Immunol. 5, 123-132.
73. Parker, K. C., Bednarek, M. A., and Coligan, J. E. (1994). Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152, 163-175.
74. Pette, M., Fujita, K., Wilkinson, D., Altmann, D., Trowsdale, J., Giegerieh, G., Hinkkanen, A., Epplen, J., Kappos, L., and Wekerle, H. (1990). Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87, 7968-7972.
75. Pettinelli, C. B., Fritz, R. B., Chou, C. H. J., and McFarlin, D. E. J. (1982). Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. Immunology 129, 1209-1211.
76. Racioppi, L., Ronchese, F., Matis, L. A., and Germain, R. N. (1993). Peptide-major histocompatibility complex class II complexes with mixed agonist-antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177, 1047-1060.
77. Raddrizzani, L., Sturniolo, T., Guenot, J., Bono, E., Gallazzi, F., Nagy, Z., Sinigaglia, F., and Hammer, J. (1997). Different strategies in peptide interaction allow HLA-DQ and DR isotypes to bind complementary peptide repertoires. J. Immunol, (in press).
78. Rammensee, H.-G., Friede, T., and Stevanovic, S. (1995). MHC ligands and peptide motifs: First listing. Immunogenetics 41, 178-228.
79. Reay, P. A., Kantor, R. M., and Davis, M. M. (1994). Use of global amino acid replacements to define the requirements for MHG binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152, 3946-3957.
80. Romagnoli, P., and Germain, R. N. (1994). The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport and peptide occupancy. J. Exp. Med. 180, 1107-1113.
81. Ronningen, K. S., Iwe, T., Halstensen, T. S., Spurkland, A., and Thorsby, E. (1989). The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diasbetes mellitus. Hum. Immunol. 26, 215-225.
82. Rothbard, J. B., and Gefter, M. L. (1991). Interaction between immunogenic peptides and MHC proteins. Annu. Rev. Immunol. 9, 527-565.
83. Rothbard, J. B., and Taylor, W. R. (1988). A sequence pattern common to T cell epitopes. EMBO J. 7, 93-100.
84. Roy, S., Scherer, M. T., Briner, T. J., Smith, J. A., and Gefter, M. L. (1989). Murine MHC polymorphism and T cell specificities. Science 244, 572-575.
85. Rudensky, A., Preston, H. P., Hong, S. C., Barlow, A., and Janeway, C. J. (1991). Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622-627.
86. Scott, J. K., and Smith, G. P. (1990). Searching for peptide ligands with an epitope library. Science 248, 386-390.
87. Sette, A., Buus, S., Colon, S., Smith, J. A., Miles, C, and Grey, H. M. (1987). Structural characteristics of an antigen required for its interaction with la and recognition by T cells. Nature 328, 395-399.
88. Sette, A., Sidney, J., Oseroff, C., del Guercio, M.-F., Southwood, S., Arrhenius, T., Powell, M. F., Colon, S. M., Gaeta, F. C, and Grey, H. M. (1993). HLA DR4w4 binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151, 3163-3170.
89. Sidney, J., Oseroff, C., Southwood. S., Wall, M., Glenn, I., Koning, F., and Sette, A. (1992). DRB1°0301 molecules recognize a structural motif distinct from the one recognized by most DRB1 alleles. J. Immunol 149, 2634-2640.
90. Sidney, J., Oseroff, C., del Guercio, M. F., Southwood, S., Ishioka, G. Y., Sakaguchi, K., Appella, E., and Sette, A. (1994). Definition of a DQ3.1 - specific binding motif. J. Immunol. 152, 4516-4525.
91. Sinigaglia, F., Romagnoli, P., Guttinger, M., Takacs, B., and Pink, J. R. L. (1992). Selection of T-cell epitopes and vaccine engineering. Methods Enzymol. 203, 370-386.
92. Smith, S. C, and Allen, P. M. (1991). Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 147, 2141-2147.
93. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., and Wiley, D. C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
94. Teh, H. S., Kisielow, P., Scott, B., Kishi, H., Uematsu, Y., Bluthmann, H., and von Boehmer, H. (1988). Thymic major histocompatibility complex antigens and the ab T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335, 229-233.
95. Thorsby, E, (1995). HLA-associated disease susceptibility-Which genes are primarily involved? Immunologic 3, 51-58.
96. Tisch, R., Yang, X.-D., Singer, S. M., Liblau, R. S., Fugger, L., and McDevitt, H. O. (1993). Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366, 72-75.
97. Tiwari, J. L., and Terasaki, P. I. (1985). "HLA and Disease Associations." Springer-Verlag, Berlin/New York.
98. Todd, J. A., Acha-Orbea, H., Bell, J. I., Chao, N., Fronek, Z., Jacob, C. O., McDermott, M., Sinha, A. A., Timmerman, L., Steinman, L., and McDevitt, H. O. (1988). A molecular basis for MHC class II-associated autoimmunity. Science 240, 1003-1009.
99. Tsuji, K., Aizawa, M., and Sasazuki, T. (1992). "Proceedings of the Eleventh International Histocompatibility Workshop and Conference." Oxford Science, Oxford.
100. Uchigata, Y., Omori, Y., Nieda, M., Kuwata, S., Tokunaga, K., and Juji, T. (1992). HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome. Lancet 340, 1467.
101. Valli, A., Sette, A., Kappos, L., Oseroff, C., Sidney, J., Miescher, G., Hochberger, M., Albert, E. D., and Adorini, L. (1993). Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Invest. 91, 616-628.
102. °0201) molecule. Immunogenetics 44, 246-253.
103. ° 0201) molecule. Eur. J. Immunol. 26, 2764-2772.
104. Verreck, F. A. W., van de Poel, A., Termijtelen, A., Anions, R., Drijfhout, J.-W., and Koning, F. (1994). Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by poo! sequencing. Eur. J. Immunol. 24, 375-379.
105. °501 molecules delineated from self-peptides. J. Immunol. 153, 1665-1673.
106. Wauben, M. H. M., Joosten, I., Schlief, A., van der See, R., Boog, C. J. P., and van Eden, W. (1994). Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide. J. Immunol. 152, 4211-4220.
107. Weiss, S. M., and Kulikowski, C. A. (1990). "Computer Systems That Learn. " Kaufman, San Mateo, CA.
108. Winchester, R. (1994). The molecular basis of susceptibility to rheumatoid arthritis. Adv. Immunol. 56, 289-466.
109. Wordsworth, B. P., Lanchbury, J. S., Sakkas, L. I., Welsh, K. I., Panayi, G. S., and Bell, J. I. (1989). HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc. Natl. Acad. Sci. USA 86, 10049-10053.
110. °0401. Arthritis Rheum. 38, 1744-1753.
111. Wucherpfennig, K. W., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J. L., and Hafler, D. A. (1994). Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179, 279-290.
112. Wucherpfennig, K. W., Yu, B., Bhol, K., Monos, D. S., Argyris, E., Karr, R. W., Ahmed, A. R., and Strominger, J. L. (1995). Structural basis for major histocompatibility complex (MHC) -linked susceptibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc. Natl. Acad. Sci. USA 92, 11935-11939.
113. Yacub, B. A., and Daif, A. K. (1988). Multiple sclerosis in Saudi Arabia. Neurology 328, 621-625.
114. Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H. L., and Hafler, D. A. (1994). Increased frequency of interleukin 2-responsive T cell specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179, 973-984.